Diagnostics Lab Meeting

Join the COVID-19 Diagnostics Evidence Accelerator  to check-up on what’s happening with the Mayo Clinic. Since Mayo’s (and their research partners at Yale University) participation in our research project looking at use patterns and performance of serological tests, they have continued to track and evaluate use of COVID-19 tests within their health system. We’ll learn how testing patterns have changed, and what information they have gathered (and generated) regarding test performance.

Alzheimer’s Evidence Accelerator Modeled On FDA COVID Project Floated By USAgainstAlzheimer’s - Pink Sheet

Patient organization exploring development of a multi-stakeholder forum on real world evidence that, among other things, could address research questions posed by the Centers for Medicare and Medicaid Services in its national coverage determination for Alzheimer’s drugs. Read more here.

Coverage

2022 Annual Public Meeting

More than 200 patient, consumer, industry, research, and government stakeholders joined the Foundation’s Annual Public Meeting of our Board of Directors on May 16, 2022. The event featured candid discussions with senior FDA leadership on topics ranging from data interoperability, food safety, and FDA’s plans for a return to in-person events. See highlights from the meeting below.

Annual Public Meeting

Woodcock Weighs in on ARPA-H - POLITICO's Prescription Pulse

If the proposed Advanced Research Projects Agency for Health is created, new treatment candidates would need to engage with FDA early on to help determine appropriate clinical testing design, FDA principal deputy commissioner Janet Woodcock said Monday at the Reagan Udall Foundation for the FDA’s annual public board of directors meeting. Read more here.

Coverage
Subscribe to